.Merck defeats revenues assumptions, increases sales expectation on tough demand for best medicines like Keytruda CNBCMerck & Co. (MRK US) Trumps Revenue Projections as Keytruda Purchases Increase BloombergMerck Inventory: Pharma Titan Posts Sturdy End Results, Yet Outlook Falls Short Client's Organization DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck beats revenue and purchases desires in the middle of Keytruda asset, yet provides combined full-year overview MarketWatch.